Endomal AT 60mg Injection is a type of medicine called an antiparasitic. It is specifically designed to treat malaria, a parasitic disease commonly transmitted through mosquito bites. This injection is not meant for preventing malaria or for treating severe cases that have affected vital organs like the brain, lungs, or kidneys.

This medication is usually administered as an injection by a healthcare professional and should never be self-administered. It is typically given in situations where taking it orally is not feasible or effective, ensuring a rapid and direct delivery into the bloodstream for prompt treatment.

Potential side effects of Endomal AT 60mg Injection may include a headache, dizziness, weakness, and loss of appetite. Additionally, some individuals may experience localized reactions at the injection site, such as pain, swelling, or redness. If any of these side effects persist or worsen over time, it is recommended to seek medical advice from your healthcare provider.

As part of the treatment process, patients receiving Endomal AT 60mg Injection may need to undergo regular blood tests once a week for a period of 4 weeks. These tests are essential for monitoring the presence of malarial parasites in the bloodstream, helping to assess the effectiveness of the medication in combating the infection and ensuring optimal recovery.